Code	Sector	Market
206A	Pharmaceuticals	Growth

Date of listing approval	2024/05/27
Expected Date	2024/07/02
Lead Underwriter	SMBC Nikko
Description

Listed Shares(total)	4,600,000
Trading Unit	100
New Shares	4,000,000
Existing Shares	600,000（only O.A.）
Shares Outstanding	PreIPO 31,354,800.00
	PostIPO 35,354,800.00
Paid Up Capital	PreIPO Y762,246,000
	PostIPO Y1,279,311,300
Expected Pricing Date	2024/06/14
Book Building Start	2024/06/17
Book Building End	2024/06/21
Fix Date	2024/06/24
Offering Starts	2024/06/25
Offering Ends	2024/06/28
Expect Pricing	Y435-Y450
Notional PER (based on previous period)	-22.79--23.57
Notional PER(based on results forecast)	-10.88--11.26
Offering Price	Y450
Offering Price PER (based on previous period)	-10.88--11.26
Offering Price PBR (based on previous period)	-13.04
Offering Price PER (based on results forecast)	-11.26
Use of Funds Raised

Units:Y1,000

Fiscal Year End:2021/09
	Consolidated	Non-consolidated
Revenue	-	58,801
Current Profit	-	-153,707
Net Profit	-	-155,989
Net Assets	-	1,092,912

Fiscal Year End:2022/09
	Consolidated	Non-consolidated
Revenue	-	554,396
Current Profit	-	78,666
Net Profit	-	72,962
Net Assets	-	1,674,930

Fiscal Year End:2023/09
	Consolidated	Non-consolidated
Revenue	-	112,926
Current Profit	-	-497,550
Net Profit	-	-526,914
Net Assets	-	1,148,015

Recent Quarter 2024/03
	Consolidated	Non-consolidated
Revenue	-	115,482
Current Profit	-	-322,855
Net Profit	-	-336,052
Net Assets	-	2,311,962

Results Forecast 2024/09
	Consolidated	Non-consolidated
Revenue	-	300,000
Current Profit	-	-914,000
Net Profit	-	-1,160,000
Net Assets	-	-

Per Share Units:Y1

Fiscal Year End:2021/09
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-	-
Equity	-7.78	-31.16

Fiscal Year End:2022/09
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-	-
Equity	2.67	-15.41

Fiscal Year End:2023/09
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-	-
Equity	-19.09	-34.50

Fiscal Year End:Interim Results 2024/03
	Consolidated	Non-consolidated
Dividend
Net Earning	-	-11.57
Equity	-	-

Fiscal Year End:Results Forecast 2024/09
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-	-39.98
Equity	-	-

■Over allotment(600,000）

Name	Address

Allocation	Underwriter	Tel
0%	Nomura	03-3211-1811
82%	SMBC Nikko	03-5644-3111
6%	Daiwa	03-5555-2111
5%	Mizuho	03-5208-3210
4%	SBI SECURITIES Co.,Ltd.	03-5562-7210
1%	IwaiCosmo Securities Co.,Ltd.	06-6229-2890
1%	Matsui	03-5216-0606
1%	Marusan	03-3272-5211